Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

A Study of AT-101 in Combination With Docetaxel in Squamous Cell Carcinoma Of The Head and Neck

This study has suspended participant recruitment.
(drug potency expiration and sponsor inability to manufacture more drug)
Information provided by (Responsible Party):
Francis (Frank) Worden, University of Michigan Cancer Center Identifier:
First received: January 20, 2011
Last updated: June 21, 2013
Last verified: March 2013
No Study Results Posted on for this Study
  Study Status: This study has suspended participant recruitment.
  Estimated Study Completion Date: January 2014
  Primary Completion Date: December 2012 (Final data collection date for primary outcome measure)